Global Antibiotic Market - Forecasts from 2019 to 2024
The global antibiotic market is projected to grow at a CAGR of XX.XX% to reach US$XX.XXX billion by 2024, from US$XX.XXX billion in 2018. The global antibiotics market is poised to grow at a sustainable rate in the forecast period due to the prevalence of bacterial infections, growing research and development investment, rising healthcare expenditure and growing pharmaceutical industry. North America and Europe are expected to hold a significant market share due to the early adoption of innovations, the highest healthcare spending of the United States and the presence of major industry players in these regions. However, rising concerns of antibiotic resistance may hinder the market growth during the forecast period.
This research study examines the current market trends related to the demand, supply, and sales, in addition to the recent developments. Major drivers, restraints, and opportunities have been covered to provide an exhaustive picture of the market. The analysis presents in-depth information regarding the development, trends, and industry policies and regulations implemented in each of the geographical regions. Further, the overall regulatory framework of the market has been exhaustively covered to offer stakeholders a better understanding of the key factors affecting the overall market environment.
Identification of key industry players in the industry and their revenue contribution to the overall business or relevant segment aligned to the study have been covered as a part of competitive intelligence done through extensive secondary research. Various studies and data published by industry associations, analyst reports, investor presentations, press releases and journals among others have been taken into consideration while conducting the secondary research. Both bottom-up and top down approaches have been utilized to determine the market size of the overall market and key segments. The values obtained are correlated with the primary inputs of the key stakeholders in the global antibiotic value chain. The last step involves complete market engineering which includes analyzing the data from different sources and existing proprietary datasets while using various data triangulation methods for market breakdown and forecasting.
Market intelligence is presented in the form of analysis, charts, and graphics to help the clients in gaining faster and efficient understanding of the global antibiotic market.
The global antibiotic market has been analyzed through following segments:
Middle East and Africa
Key insights offered
What will be the global antibiotic market size from 2018 to 2024?
How are the major drivers and restraints affecting the global antibiotic market growth and the opportunities which exist for key vendors?
Which segment and region will drive or lead the market growth and why?
A comprehensive analysis of competitive landscape and key market participants’ behaviour
Key strategies being adopted by vendors, with in-depth analysis along with their impact on competition and market growth.
Novartis Pharmaceuticals Corporation
Gilead Sciences, Inc.
F. Hoffmann-La Roche Ltd.
MELINTA THERAPEUTICS, INC.
Sun Pharmaceutical Industries Ltd.
Dr. Reddy’s Laboratories Ltd.